TY - JOUR
T1 - Evaluation of pharmacy-based HIV testing in a high-risk New York city community
AU - Amesty, Silvia
AU - Crawford, Natalie D.
AU - Nandi, Vijay
AU - Perez-Figueroa, Rafael
AU - Rivera, Alexis
AU - Sutton, Madeline
AU - Weidle, Paul J.
AU - Willis, Leigh
AU - Smith, Dawn K.
AU - Hernandez, Carolyn
AU - Harripersaud, Katherine
AU - Lewis, Crystal Fuller
N1 - Publisher Copyright:
© Mary Ann Liebert, Inc. 2015.
PY - 2015/8/1
Y1 - 2015/8/1
N2 - Blacks/Hispanics face limited access to HIV testing. We examined in-pharmacy HIV testing among customers in pharmacies participating in a nonprescription syringe program in New York City. Participants were recruited in two pharmacies to complete a survey and receive an optional HIV test. Bivariate and multivariable analyses were performed to examine associations of demographics and risk behaviors with receiving in-pharmacy HIV testing. Most participants were male (55%), black (80%), had used hard drugs (88%), and 39.5% received in-pharmacy HIV testing. Being female (AOR=2.24; 95%CI 1.24-4.05), having multiple sex partners (AOR=1.20; 95% CI 1.06-1.35), having an HIV test more than 12 months ago (AOS=4.06; CI 1.85-8.91), injecting drugs in last 3 months (AOR=2.73; 95% CI 1.31-5.69) and having continuous care (AOR=0.32; 95% CI 0.17-0.58) were associated with receiving in-pharmacy HIV test. These data provide evidence of in-pharmacy HIV testing reaching persons at risk of HIV. HIV testing in pharmacies may complement existing strategies.
AB - Blacks/Hispanics face limited access to HIV testing. We examined in-pharmacy HIV testing among customers in pharmacies participating in a nonprescription syringe program in New York City. Participants were recruited in two pharmacies to complete a survey and receive an optional HIV test. Bivariate and multivariable analyses were performed to examine associations of demographics and risk behaviors with receiving in-pharmacy HIV testing. Most participants were male (55%), black (80%), had used hard drugs (88%), and 39.5% received in-pharmacy HIV testing. Being female (AOR=2.24; 95%CI 1.24-4.05), having multiple sex partners (AOR=1.20; 95% CI 1.06-1.35), having an HIV test more than 12 months ago (AOS=4.06; CI 1.85-8.91), injecting drugs in last 3 months (AOR=2.73; 95% CI 1.31-5.69) and having continuous care (AOR=0.32; 95% CI 0.17-0.58) were associated with receiving in-pharmacy HIV test. These data provide evidence of in-pharmacy HIV testing reaching persons at risk of HIV. HIV testing in pharmacies may complement existing strategies.
UR - http://www.scopus.com/inward/record.url?scp=84938310242&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84938310242&partnerID=8YFLogxK
U2 - 10.1089/apc.2015.0017
DO - 10.1089/apc.2015.0017
M3 - Article
C2 - 26217930
AN - SCOPUS:84938310242
SN - 1087-2914
VL - 29
SP - 437
EP - 444
JO - AIDS Patient Care and STDs
JF - AIDS Patient Care and STDs
IS - 8
ER -
